<- Go Home
China SXT Pharmaceuticals, Inc.
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.
Market Cap
$1.7M
Volume
361.6K
Cash and Equivalents
$12.1M
EBITDA
-$1.9M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$554.0K
Profit Margin
28.73%
52 Week High
$6.39
52 Week Low
$0.45
Dividend
N/A
Price / Book Value
0.08
Price / Earnings
-0.13
Price / Tangible Book Value
0.08
Enterprise Value
-$6.7M
Enterprise Value / EBITDA
3.69
Operating Income
-$2.1M
Return on Equity
21.65%
Return on Assets
-4.96
Cash and Short Term Investments
$12.1M
Debt
$3.7M
Equity
$13.9M
Revenue
$1.9M
Unlevered FCF
-$1.2M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium